Finance

Beta
Lists
CGTX:NASDAQ
Cognition Therapeutics Inc
$1.29
-5.15%
(-0.070) 1D
$1.28
-0.67% (-0.0086)
After hours
Closed: Jun 5, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CGTX...
Open
$1.33
High
$1.33
Low
$1.22
Mkt. cap
115.45M
Avg. vol.
1.04M
Volume
1.15M
52-wk high
$3.83
52-wk low
$0.25
EPS
-$0.26
Beta
1.75
Shares outstanding
89.50M
No. of employees
14
Open
$1.33
High
$1.33
Low
$1.22
Mkt. cap
115.45M
Avg. vol.
1.04M
Volume
1.15M
52-wk high
$3.83
52-wk low
$0.25
EPS
-$0.26
Beta
1.75
Shares outstanding
89.50M
No. of employees
14
Analyst outlook
Analyst Ratings
Based on 2 analysts giving stock ratings to CGTX in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12 month forecast
Based on 2 Wall Street analysts offering 12 month price targets for CGTX in the last 3 months.
Highest
Current $1.29
$4.00 (+210.08%)
Average
$3.50 (+171.32%)
Lowest
$3.00 (+132.56%)
News stories
From sources across the web
About Cognition Therapeutics Inc
CEO-
Employees14
FoundedJan 1, 2007
Headquarters-
SectorPharmaceutical industry
Websitecogrx.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
11.48M
3.77M
11.15M
6.12M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.50M
2.60M
2.52M
2.70M
Operating expense
13.98M
6.38M
13.67M
8.82M
Total operating expenses
13.98M
6.38M
13.67M
8.82M
Operating income
-13.98M
-6.38M
-13.67M
-8.82M
Other non operating income
7.25M
1.44M
10.33M
4.25M
EBT including unusual items
-6.73M
-4.93M
-3.34M
-4.57M
EBT excluding unusual items
-6.73M
-4.93M
-3.34M
-4.57M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-6.73M
-4.93M
-3.34M
-4.57M
Net profit margin
-
-
-
-
Earnings per share
-0.11
-0.06
-0.02
-0.05
Interest and investment income
-
-
-
-
Interest expense
-3.00K
-
-5.00K
-5.00K
Net interest expenses
-3.00K
-
-5.00K
-5.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-13.96M
-6.36M
-13.66M
-8.81M
Gain or loss from assets sale
-
-
41.00K
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer